SCHEMBL5167993

SCHEMBL5167993

O=C1Nc2cc(-c3ccccc3)ccc2C1=CNc1cccc(CO)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
PDGFRB P09619 6/20 0.43
KDR P35968 6/20 0.43
FGFR1 P11362 4/20 0.43
EGFR P00533 2/20 0.43
FLT3 P36888 3/20 0.42
KIT P10721 1/20 0.42
FLT4 P35916 1/20 0.42
CHEK1 O14757 5/20 0.41
AURKB Q96GD4 2/20 0.41
ABL1 P00519 2/20 0.41
LRRK2 Q5S007 2/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426677 1.00 MAOA (0.46) MAOAMAOBPDGFRBKDRFGFR1
SCHEMBL4987427 0.86 ALDH1A1 (0.49) PDGFRBKDRFLT3ALDH1A1LMNA
SCHEMBL4987422 0.86 ALDH1A1 (0.49) PDGFRBKDRFLT3ALDH1A1LMNA
SCHEMBL7706679 0.85 RET (0.42) PDGFRBKDRFGFR1CHEK1AURKB
SCHEMBL7706680 0.85 RET (0.42) PDGFRBKDRFGFR1CHEK1AURKB
SCHEMBL5893993 0.84 TGM2 (0.45) KDRNPC1ALDH1A1MAPTRAB9A
SCHEMBL5893997 0.84 TGM2 (0.45) KDRNPC1ALDH1A1MAPTRAB9A
SCHEMBL7703523 0.84 TGM2 (0.45) KDRNPC1ALDH1A1MAPTRAB9A
SCHEMBL5170541 0.82 TDP2 (0.47) MAOAMAOBPDGFRBKDRFGFR1
SCHEMBL5424640 0.82 TDP2 (0.47) MAOAMAOBPDGFRBKDRFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350747-B1 PROTEIN SERINE/THREONINE KINASE AND PROTEIN TYROSINE KINASE ENZYME INHIBITORS; ANGIOGENESIS INHIBITORS; ANTITUMOR AND ANTIPROLIFERATIVE AGENTS GLAXO WELLCOME INC. 2002-02-26 US claimed
EP-1165514-A1 3-(ANILINOMETHYLENE) OXINDOLES AS PROTEIN TYROSINE KINASE AND PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2002-01-02 EP claimed
WO-2000056710-A1 3-(ANILINOMETHYLENE) OXINDOLES AS PROTEIN TYROSINE KINASE AND PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2000-09-28 WO claimed
US-20070213403-A1 TAMOXIFEN RESPONSE IN PRE-AND POSTMENOPAUSAL BREAST CANCER PATIENTS FORSKARPATENT I SYD AB (SE) 2007-09-13 US disclosed
EP-1773309-A1 TAMOXIFEN RESPONSE IN PRE-AND POSTMENOPAUSAL BREAST CANCER PATIENTS Forskarpatent i Syd AB (SE) 2007-04-18 EP disclosed
WO-2006004545-A1 TAMOXIFEN RESPONSE IN PRE-AND POSTMENOPAUSAL BREAST CANCER PATIENTS FORSKARPATENT I SYD AB (SE) 2006-01-12 WO disclosed